Blockbuster drug Humira finally faces lower-cost rivals After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less. Sydney Lupkin
Denied abortion for a doomed pregnancy, she tells Texas court: 'There was no mercy' Women who had complicated and tragic pregnancies are suing Texas over its abortion bans. A hearing had emotional testimony in an Austin courtroom Wednesday. The state wants the case dismissed. Selena Simmons-Duffin
UW researcher says there's a simple way to help people addicted to fentanyl Addiction researchers say the FDA should revisit their prescribing guidelines for buprenorphine, one of the main medications that can help people addicted to fentanyl or other opioids by reducing withdrawal symptoms and cravings. Eilís O'Neill
In-N-Out Burger bans employees in 5 states from wearing masks The new mask policy will apply to employees in Arizona, Colorado, Nevada, Texas and Utah. Employees in California and Oregon can choose to wear a company-provided N95 mask. Jonathan Franklin
Copycat drugs could end Humira's reign as the prominent arthritis treatment The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign. Sydney Lupkin
Russia's nixing of Ukraine grain deal deepens worries about global food supply Since the war began, there's been concern about getting Ukrainian grain to countries in need. A deal was struck in 2022 to keep exports flowing — but Russia put an end to it on Monday. Andrew Connelly
After a historic downturn due to the pandemic, childhood immunizations are improving New data from the World Health Organization and UNICEF show that the number of children getting vaccinated is rebounding globally. Ashley Westerman
'Hospital-at-home' trend means family members must be caregivers — ready or not It's taking off around the country: Treatment at home for patients sick enough to be in a hospital, but stable enough to be home. Are family caregivers ready for all the responsibility? Kat McGowan
An experimental Alzheimer's drug has been shown to slow the disease in a new study A large study shows that an experimental Alzheimer's drug can slow down the disease at least as much as a drug approved by the FDA. (This first aired on All Things Considered on July 17, 2023.) Jon Hamilton
